Outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) according to the presence of the EGFR T790M mutation and BRCA1 mRNA expression levels in pretreatment biopsies

被引:5
|
作者
Rosell, R.
Molina, M. A.
Costa, C.
Taron, M.
Bertran-Alamillo, J.
Mayo, C.
Benlloch, S.
Moran, T.
Cardenal, F.
Porta, R.
机构
[1] Catalan Inst Oncol, Badalona, Spain
[2] USP Inst Univ Dexeus, Pangaea Biotech, Barcelona, Spain
[3] USP Dexeus Univ Inst, Pangaea Biotech, Barcelona, Spain
[4] USP Inst Dexeus, Pangaea Biotech, Barcelona, Spain
[5] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain
[6] Bellvitge Hosp, Catalan Inst Oncol, Barcelona, Spain
[7] Hosp Josep Trueta, Catalan Inst Oncol, Girona, Spain
关键词
D O I
10.1200/jco.2010.28.15_suppl.7514
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7514
引用
收藏
页数:1
相关论文
共 50 条
  • [31] EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients
    Zheng, Qiufan
    Hong, Shaodong
    Huang, Yan
    Zhao, Hongyun
    Yang, Yunpeng
    Hou, Xue
    Zhao, Yuanyuan
    Ma, Yuxiang
    Zhou, Ting
    Zhang, Yaxiong
    Fang, Wenfeng
    Zhang, Li
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 9 (01):
  • [32] Risk Factors for Developing T790M Mutation in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer
    Ouyang, W.
    Xie, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E526 - E526
  • [33] Non-invasive urine testing of EGFR activating mutation and T790M resistance mutation in non-small cell lung cancer
    Berz D.
    Raymond V.M.
    Garst J.H.
    Erlander M.G.
    [J]. Experimental Hematology & Oncology, 5 (1)
  • [34] Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
    Watanabe, Masaru
    Kawaguchi, Tomoya
    Isa, Shun-ichi
    Ando, Masahiko
    Tamiya, Akihiro
    Kubo, Akihito
    Saka, Hideo
    Takeo, Sadanori
    Adachi, Hirofumi
    Tagawa, Tsutomu
    Kakegawa, Seiichi
    Yamashita, Motohiro
    Kataoka, Kazuhiko
    Ichinose, Yukito
    Takeuchi, Yukiyasu
    Sakamoto, Kazuhiro
    Matsumura, Akihide
    Koh, Yasuhiro
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (15) : 3552 - 3560
  • [35] Role of T790M Mutation in EGFR-TKI Rechallenge for Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer
    Zhang, Qiu-Yi
    Ke, E-E
    Deng, Wei
    Niu, Fei-Yu
    Zhao, Ning
    Su, Jian
    Chen, Zhi-Hong
    Yang, Jin-Ji
    Xu, Chong-Rui
    Yan, Hong-Hong
    Wu, Yi-Long
    Zhou, Qing
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S271 - S271
  • [36] ROR1 AS A NOVEL THERAPEUTIC TARGET FOR EGFR-MUTANT NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS WITH THE EGFR T790M MUTATION
    Karachaliou, Niki
    Drozdowskyj, Ana
    Costa, Carlota
    Angel Molina-Vila, Miguel
    Gimenez-Capitan, Ana
    Vergnenegre, Alain
    Massuti, Bartomeu
    Moran, Teresa
    Majem, Margarita
    Felip, Enriqueta
    Carcereny, Enric
    Garcia-Campelo, Rosario
    Viteri, Santiago
    Heidecke, Cordula
    Estrada-Tejedor, Roger
    Teixido, Jordi
    Bivona, Trever
    Giannikopoulos, Petros
    Ono, Mayumi
    Rosell, Rafael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1048 - S1048
  • [37] Impact of bevacizumab in combination with erlotinib on EGFR-mutatant non-small cell lung cancer xenograft models with T790M mutation or MET amplification
    Furugaki, K.
    Fukumura, J.
    Iwai, T.
    Yorozu, K.
    Yanagisawa, M.
    Moriya, Y.
    Kurasawa, M.
    Yamamoto, K.
    Suda, K.
    Mizuuchi, H.
    Mitsudomi, T.
    Harada, N.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S611 - S612
  • [38] Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer
    John, Thomas
    Bowden, Jeffrey J.
    Clarke, Stephen
    Fox, Stephen B.
    Garrett, Kerryn
    Horwood, Keith
    Karapetis, Christos S.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (04) : 296 - 303
  • [39] Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification
    Furugaki, Koh
    Fukumura, Junko
    Iwai, Toshiki
    Yorozu, Keigo
    Kurasawa, Mitsue
    Yanagisawa, Mieko
    Moriya, Yoichiro
    Yamamoto, Kaname
    Suda, Kenichi
    Mizuuchi, Hiroshi
    Mitsudomi, Tetsuya
    Harada, Naoki
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (04) : 1024 - 1032
  • [40] Afatinib increases sensitivity to radiation in non-small cell lung cancer cells with acquired EGFR T790M mutation
    Zhang, Shirong
    Zheng, Xiaoliang
    Huang, Haixiu
    Wu, Kan
    Wang, Bing
    Chen, Xufeng
    Ma, Shenglin
    [J]. ONCOTARGET, 2015, 6 (08) : 5832 - 5845